The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effectiveness and safety of camrelizumab in advanced esophageal cancer: A prospective multicenter observational cohort studies (ESCORT-RWS).
 
Zhihao Lu
No Relationships to Disclose
 
Jun Zhao
No Relationships to Disclose
 
Zhe Yang
No Relationships to Disclose
 
Na Li
No Relationships to Disclose
 
Junsheng Wang
No Relationships to Disclose
 
Shuanghu Yuan
No Relationships to Disclose
 
Yusheng Wang
No Relationships to Disclose
 
Suyi Li
No Relationships to Disclose
 
Fengming Ran
No Relationships to Disclose
 
Yinghua Ji
Research Funding - AoSaiKang (Inst); CSPC Pharmaceutical Group (Inst); Hualan Bio (Inst)
 
Yanqiao Zhang
No Relationships to Disclose
 
Chen Wang
No Relationships to Disclose
 
Lixin Wan
No Relationships to Disclose
 
Ming Wang
No Relationships to Disclose
 
Liang Liang
No Relationships to Disclose
 
Xiaofang Dai
No Relationships to Disclose
 
Guanghui Cheng
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Peng Zhen
No Relationships to Disclose
 
Lin Shen
No Relationships to Disclose